Sign Out
Preparation for Administration: Menactra is a clear to slightly turbid solution. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. If any of these conditions exist, the vaccine should not be administered.
Withdraw the 0.5 mL dose of vaccine from the single-dose vial using a sterile needle and syringe.
Dose and Schedule: Menactra is administered as a 0.5 mL dose by intramuscular injection. Do not administer this product intravenously or subcutaneously.
Primary Vaccination: In children 9 through 23 months of age, Menactra is given as a 2-dose series three months apart.
Individuals 2 through 55 years of age, Menactra is given as a single dose.
Booster Vaccination: A single booster dose may be given to individuals 15 through 55 years of age at continued risk for meningococcal disease, if at least 4 years have elapsed since the prior dose.
